Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Chi V. Dang
An Epigenetic Pathway Regulates Sensitivity of Breast Cancer Cells to HER2 Inhibition via FOXO/c-Myc Axis
Cancer Cell
Cancer Research
Oncology
Cell Biology
Glucose-Independent Glutamine Metabolism via TCA Cycling for Proliferation and Survival in B Cells
Cell Metabolism
Cell Biology
Molecular Biology
Physiology
Related publications
Danazol Mediates Collateral Sensitivity via STAT3/Myc Related Pathway in Multidrug-Resistant Cancer Cells
Scientific Reports
Multidisciplinary
Pharmacologic Inhibition of mTOR Improves Lapatinib Sensitivity in HER2-Overexpressing Breast Cancer Cells With Primary Trastuzumab Resistance
Anti-Cancer Agents in Medicinal Chemistry
Cancer Research
Molecular Medicine
Pharmacology
NRF2 Regulates HER2 and HER3 Signaling Pathway to Modulate Sensitivity to Targeted Immunotherapies
Oxidative Medicine and Cellular Longevity
Biochemistry
Medicine
Cell Biology
Aging
De-Repression of the P21 Promoter in Prostate Cancer Cells by an Isothiocyanate via Inhibition of HDACs and C-Myc
International Journal of Oncology
Cancer Research
Oncology
PIN1 Maintains Redox Balance via the C-Myc/Nrf2 Axis to Counteract Kras-Induced Mitochondrial Respiratory Injury in Pancreatic Cancer Cells.
Cancer Research
Cancer Research
Oncology
Breast Cancer Stem Cells in HER2-negative Breast Cancer Cells Contribute to HER2-mediated Radioresistance and Molecular Subtype Conversion: Clinical Implications for Serum HER2 in Recurrent HER2-negative Breast Cancer
Oncotarget
Oncology
Targeting HER2+ Breast Cancer: The TBK1/IKK-Epsilon Axis
Oncoscience
Cancer Research
Oncology
JQ1, an Inhibitor of the Epigenetic Reader BRD4, Suppresses the Bidirectional MYC-AP4 Axis via Multiple Mechanisms
Oncology Reports
Medicine
Cancer Research
Oncology
Pharmacological Targeting of MYC-regulated IRE1/XBP1 Pathway Suppresses MYC-driven Breast Cancer
Journal of Clinical Investigation
Medicine
